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ATOT = total concentration of weak acids; CA = carbonic anhydrase; CD = collecting duct; DCT = distal convoluted tubule; dRTA = distal renal
tubular acidosis; kNBC = kidney Na+/HCO3
– cotransporter; NAE = net acid excretion; PCO2 = partial CO2 tension; PHA = pseudohypoaldostero-
nism; ROMK = renal outer medullar K+ channel; RTA = renal tubular acidosis; SID = strong ion difference; SLC = solute carrier; TSC = thiazide-
sensitive cotransporter.
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Abstract
The Canadian physiologist PA Stewart advanced the theory that
the proton concentration, and hence pH, in any compartment is
dependent on the charges of fully ionized and partly ionized
species, and on the prevailing CO2 tension, all of which he dubbed
independent variables. Because the kidneys regulate the
concentrations of the most important fully ionized species ([K+],
[Na+], and [Cl–]) but neither CO2 nor weak acids, the implication is
that it should be possible to ascertain the renal contribution to
acid–base homeostasis based on the excretion of these ions. One
further corollary of Stewart’s theory is that, because pH is solely
dependent on the named independent variables, transport of
protons to and from a compartment by itself will not influence pH.
This is apparently in great contrast to models of proton pumps and
bicarbonate transporters currently being examined in great
molecular detail. Failure of these pumps and cotransporters is at
the root of disorders called renal tubular acidoses. The
unquestionable relation between malfunction of proton
transporters and renal tubular acidosis represents a problem for
Stewart theory. This review shows that the dilemma for Stewart
theory is only apparent because transport of acid–base equivalents
is accompanied by electrolytes. We suggest that Stewart theory
may lead to new questions that must be investigated
experimentally. Also, recent evidence from physiology that pH may
not regulate acid–base transport is in accordance with the
concepts presented by Stewart.
Introduction
Renal tubular acidoses (RTAs) are forms of metabolic
acidoses that are thought to arise from a lack of urine
excretion of protons or loss of bicarbonate (HCO3
–) due to a
variety of tubular disorders. Characteristically, this causes a
hyperchloraemic (non-anion gap) acidosis without impaired
glomerular filtration. Molecular studies have identified genetic
or acquired defects in transporters of protons and HCO3
– in
many forms of RTA. However, at the same time these trans-
porters have been found also to be involved in transport of Cl–
and Na+. Furthermore, in a few cases RTA has been associa-
ted with primary defects in electrolyte transporters alone.
The core of Stewart theory is that transport of protons as
such is unimportant to regulation of pH. In contrast, the
theory states that acid–base homeostasis is directly
regulated by electrolyte transport in the renal tubules. H+ is
effectively a balancing requirement imposed by physical
chemistry. Accounting for how this occurs will probably lead
to an improved understanding of homeostasis.
We begin the review by describing the classical formulation
of the renal regulation of acid–base homeostasis. We then
describe the quantitative physical chemistry notion of
acid–base as described by Stewart (henceforth called the
‘physicochemical approach’). On this basis we analyze some
of the mechanisms that are active in RTA. We show that the
physicochemical approach may lead to new questions that
can be pursued experimentally to supplement insights already
gained with classical theory. Several authors have suggested
that the physicochemical approach could be used to the
benefit of our understanding of RTA [1,2].
The kidney as regulator of acid–base balance
According to traditional concepts [3], daily acid production is
calculated as the combined excretion of sulphate anion
(SO4
2–) and organic anions in the urine, whereas renal
elimination of acid equivalents is computed as the combined
titrable acidity + ammonium – excreted HCO3
–, called net
acid excretion (NAE). Cohen and coworkers [4] reviewed
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evidence indicating that the traditional view may be incon-
sistent with observations in patients in renal failure and in a
number of experimental studies. In one of the studies
assessed, Halperin and coworkers [5] examined rats loaded
with extra alkali on top of already basic ordinary rat chow.
Amazingly, increasing unmeasured organic anions had a 10-
fold greater effect on alkali disposal than did changes in NAE,
as traditionally computed. Similar findings had already been
reported by Knepper and coworkers [6] in 1989. That
acid–base balance is always accounted for by standard
measurements may therefore be disputed. Although fervently
rejected [3], this has given rise to a proposal of a new
classification system for NAE that includes the regulation of
loss of organic anions or potential HCO3
– [7].
Difficulties in measuring titrable acidity and organic anions
are one main source of disagreement with regard to
acid–base homeostasis [4] both in normal persons and in
those with renal impairment [8]. A recent Danish study [9]
reinforced the concept from studies of healthy humans
exposed to acid loads that nonmetabolizable base excretion
is important to renal regulation of acid–base homeostasis.
Central to renal acid–base physiology is excretion of
ammonium. One view [10] is that ammonium is produced as
NH4
+ in large quantities from hydrolysis of peptide bonds,
and its excretion in urine has no bearing on acid–base
chemistry except for the fact that for nitrogen balance it
would otherwise have to be converted to urea – a process
seen to consume bicarbonate. Exactly this argument was
used again by Nagami [11] in an authoritative review of renal
ammonia production and excretion. Most recently a study of
normal individuals [12] showed that ureagenesis increased
during experimental acidosis produced by CaCl2. This
contrasted with the authors’ expectations because urea-
genesis was supposed to cost alkali.
However, the traditional view is that NH4
+ excretion is one of
the most important mechanisms for eliminating metabolic
acid equivalents because the leftover from deamination of
glutamine is effectively bicarbonate and the process comes
to a halt if NH4
+ is not eliminated [13]. As stated in recent
accounts, this view also accounts for the bicarbonate toll of
ureagenesis [14] but the details of regulation and overall
stoichiometry are still debated. However, it seems that the
handling of NH4
+ in the kidney is of great importance
because a complicated network of transport mechanisms
have evolved [11]. Most recently, a new group of putative
NH4
+ (and NH3?) transporters related to the rhesus group of
proteins has been described [15]. As far as we know, the
result of missing one or more of these transporters on
acid–base balance is not yet known, and because of
redundancy it could be limited. Finally, apart from being a
transported quantity that is of importance per se, NH4
+ has
also been found to influence a number of other tubular
processes that are involved in acid–base regulation [16,17].
Hence, although there can be no doubt that excretion of
NH4
+ is important to acid–base homeostasis, it is not entirely
clear why this is so. We suggest that the physicochemical
approach to acid–base provides a more coherent picture of
the role played by NH4
+.
The Stewart approach to acid–base chemistry
Here we consider the approach to acid–base chemistry
proposed by PA Stewart [18,19]. Biological fluids are
dominated by a high concentration of water, approximately
55 mol/l. Physical chemistry determines the dissociation of
water into protons and hydroxyl ions. If the determinants of
that equilibrium are unchanged, then concentration of
protons, and therefore pH, will be as well.
A number of important substances (e.g. many salts)
dissociate completely to ions, when dissolved in water,
whereas water itself dissociates to a very minor degree.
Nonetheless, the dissociation of water into H+ and OH–
provides an inexhaustible source and sink of acid–base
equivalents. The proton concentration, and hence pH, is
determined by the requirement that positive and negative
charges must balance and by the combined equations that
govern dissociations of involved species. The approach is
formally based on analysis of separate compartments and leads
to the result that [H+] in a compartment of physiological fluid is
determined by the concentrations of fully ionized substances
(strong ion difference [SID]), partial CO2 tension (PCO2) and
partly dissociated substances termed ‘weak acids’ in that
compartment.
In a solution containing only fully dissociated salt (e.g. NaCl)
the requirement for electrical neutrality leads to the following
relation:
(Na+ + H+) – (Cl– + OH–) = 0 (1)
The water dissociation equilibrium must also be obeyed:
[H+] × [OH–] = Kw × [H2O] ≈ Kw′ (2)
The SID is defined as the difference between fully
dissociated cations and anions, and in the NaCl solution it is
calculated as follows:
SID = [Na+] – [Cl–] (3)
Combining Eqns 1, 2 and 3 leads to the following relation:
[H+]2 + SID × [H+] – Kw′ = 0 (4)
The positive solution to this second-degree polynomial yields:
SID
[H+] =  –        + √ [Kw′ + (SID/2)2] (5)
2575
And from Eqn 2:
SID
[OH–] =  –        + √ [Kw′ + (SID/2)2] (6)
2
Hence, in a compartment/solution containing NaCl or similar
salt solution, the proton concentration is simply determined
by SID and the water ion product (Kw). Addition or removal of
protons or hydroxyl ions may or may not be possible but will
not change pH [20].
It is possible that the development of Stewart concepts to
this extent will suffice for analysis of renal influences on
acid–base homeostasis from a whole body or balance
perspective. However, to present the theory of Stewart in a
more complete form, we may also add weak acids and CO2
to this framework. A full account of the Stewart approach
with some later adaptations is available in a previous issue of
this journal (see the report by Corey [21]).
Adding a weak acid, specifically a substance that participates
in proton exchanges and hence that has a charge that is
dependent on pH, Stewart showed that Eqn 7 had to be
satisfied.
[H+]3 + (KA + SID) × [H+]2 + (KA × 
[SID – ATOT] – Kw) × [H+] – KA × Kw′ = 0 (7)
Where KA is the equilibrium constant and ATOT is the total
concentration of weak acids. To arrive at a satisfactory
explanation for acid–base homeostasis from the whole body
perspective, the pervasive effect of continuing production
and transport and pulmonary excretion of CO2 evidently must
be taken into account. To do this, two more equations were
needed:
[H+] × [HCO3
–] = KC × PCO2 (8)
[H+] × [CO3
2–] = K3 × [HCO3
–] (9)
Solving these together, Stewart’s model in its most
integrative form is now given by Eqn 10:
[H+]4 + ([SID] + KA) × [H+]3 + 
(KA × [[SID] – [ATOT]] – KW – KC × PCO2) × 
[H+]2 – (KA × [KW + KC × PCO2] – K3 × KC × PCO2) ×
[H+] – KA × K3 × KC × PCO2 = 0 (10)
These equations have explicit entries of constants and
concentrations or tensions, but the practical use of the
framework must be developed with detail sufficient to deal
with the problem at hand. In plasma, other strong ions (e.g.
Ca2+ and lactate) and weak acids are frequently found but
they are treated on an equal footing.
A number of studies have shown that this algebra yields an
accurate description or prediction of acid–base measure-
ments. More importantly, however, the physicochemical
approach may lead to a better understanding of mechanisms
that are active in disease and treatment. An example of what
may be accomplished is the successful application of the
physicochemical approach to exercise physiology. Here, the
ability of the independent variables to predict measured pH
has been proven (correlation 0.985), but more importantly
changes over time and between the different body
compartments in these independent variables explain how a
range of interventions influence acid–base as a part of
muscle physiology [22].
CO2 is transported in the body as a number of species and
because the processes involved have variable latency (e.g.
the Cl–/HCO3
– exchanger band3 in red blood cells [23]),
widely differing values of PCO2 are found in the body [24].
The physicochemical approach, focusing as it does on each
compartment separately and having no special interest in the
quantitatively lesser compartment of arterial blood, is at no
disadvantage relative to conventional concepts in elucidating
this difficult area. Although this is less of a problem when
overall renal regulation of acid–base homeostasis is
considered, notwithstanding that urine CO2 may be of utility
when diagnosing variants of RTA [25], it is a major problem
with respect to understanding the underlying cellular
transport processes. Further, recent results showing the
complicated organization of transporters together in
physically connected complexes indicate that much work will
be needed if we are to understand the integrated molecular
details of anion transport and CO2 metabolism in renal
tubules [26].
Whereas the physicochemical approach explains how pH is
determined from independent variables, when applying this to
urine the focus is not on regulation of urine pH but on the
renal regulation of the independent variables that determine
plasma and whole body acid–base balance. These
independent variables are the SID, weak acids, and PCO2.
Hence, from the point of view of the physicochemical
approach, assessing urine with the aim of understanding the
renal contribution to acid–base balance amounts to deducing
its effects on the independent variables for a specified body
compartment. It has been reported that the concepts of SID
and weak acids may be blurred. For example, pH may
influence the behaviour of species as either strong ions
(components of SID) or weak acids [27], and this applies, for
instance, to phosphates and proteins. Furthermore, neither
Na+ nor Ca2+ is invariably and totally dissociated, as implied
by the common SID construct [28].
One important but thus far undeveloped aspect of the
Stewart approach to whole body acid balance problems is
that the independent variables for the extracellular
compartment normally in focus may be only partly relevant to
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the much larger intracellular compartment. Excretion of large
amounts of potassium, for example, may be minimally relevant
to SID in the extracellular compartment but may, depending
on the circumstances, be crucial to intracellular SID [29].
It is evident that there will be differences in the approach to
accounting for acid–base balance in the classical compared
with the physicochemical approach. In the classical setting
we must perform difficult titrations [4] and measurements of
NH4
+, PCO2 and pH to compute a [HCO3
–] after correction of
pK for ionic strength. Every part of this is complicated, and
the overall results with regard to our understanding of whole
body balance are not universally accepted [4]. In the
physicochemical approach, renal involvement in acid–base
balance is manifested in its influence on independent
variables – nothing more and nothing less. For a first
approximation, this is the urine excretion of SID components,
principally Na+ and Cl– when extracellular homeostasis alone
is considered. It will be a practical matter to determine the
extent to which the Stewart approach will be complicated by
problems in computing both SID and weak acids in urine.
In the physicochemical approach, the urinary excretion of
NH4
+ or organic anions will be important for acid–base
balance only to the extent that it influences SID in a body
compartment. Excretion of organic anions is from this
perspective a way to excrete Na+ without Cl– and thereby
decrease SID in the body. This will result in increasing plasma
H+, no matter what the nature of the organic anion is. This
hypothesis can be tested experimentally. On a similar footing,
NH4
+ excretion could be understood as means to excrete Cl–
without Na+ in order to increase SID in the body. However,
apart from their influence on SID, the excretion of these
substances may convey important information about
underlying pathophysiological processes. Hence, Kellum [30]
has proposed that, when analyzing the mechanism of
hyperchloraemic acidosis, an initial distinction could be made
between states in which the kidney reacted normally (i.e.
increasing the excretion of Cl– relative to Na+ and K+ by
augmenting NH4
+ excretion and so causing urine SID to be
more negative) and situations where, in spite of acidosis, the
kidney continues to decrease whole body SID by excreting
more Na+ and K+ than Cl–. This will typically be the case in
distal RTA (dRTA) without increased NH4
+ excretion during
acidosis.
Overview on renal tubular acidoses
Several types of RTA may be discerned [31]: proximal
(type 2), distal (type 1), mixed (type 3), and a heterogeneous
group of disorders characterized by hyperkalaemia and
acidosis (type 4). RTA is a hyperchloraemic rather than an
anion-gap-type metabolic acidosis. Typically, renal function
(glomerular filtration rate) is unimpaired and the acidosis is
not simply caused by absence of renal clearance. RTA must
be separated from other forms of hyperchloraemic acidosis,
some of which (e.g. the hyperchloraemic acidosis that occurs
following saline infusion) are very important in the intensive
care setting [32,33].
Proximal renal tubular acidosis (type 2)
Proximal RTA is classically characterized by impaired proximal
reclamation of bicarbonate. This may be isolated or combined
with other proximal tubular defects, and it may be congenital
or acquired.
Proximal bicarbonate reabsorption is still incompletely under-
stood [34]. Most of the bicarbonate [35] leaves the tubule
lumen as CO2 following sodium dependent H+ secretion via
Na+/H+ exchanger isoforms or (to a minor extent) vacuolar
H+-ATPase, apical anion exchange via formate enhanced
Slc26a6, or other mechanisms [36], but some bicarbonate
transport may also be paracellular [37]. The transport
requires both membrane bound carbonic anhydrase (CA)
type 4 and intracellular CA-2.
Among hereditary forms of RTA type 2 [38] is a very rare
autosomal dominant disorder, the mechanism of which is
unknown, but isoform 3 of the Na+/H+ exchanger (solute
carrier [SLC]9A3) is a candidate. More common is an
autosomal recessive form with ocular abnormalities, related to
mutations in kidney Na+/HCO3
– cotransporter (kNBC)1
(SLC4A4) gene, which encodes the basolateral, electrogenic
Na+/3(HCO3
–) cotransporter. kNBC1 activity leads to a
depolarization of the membrane and to extracellular
accumulation of HCO3
–. A recently identified potassium
channel, named TASK2, recycles K+ and repolarizes the
potential, and mice that are deficient in this channel had
metabolic acidosis associated with insufficient proximal
bicarbonate reabsorption [39]. Recent studies of the
regulation of kNBC1 and integrated transport in the proximal
tubule have shown that, in addition to a substrate interaction,
there is also a true macromolecular interaction between CA-2
and kNBC1 [40].
Sporadic forms, which are not yet characterized, also occur.
However, most cases of proximal RTA are secondary and a
host of associations have been described. Blockade of CA-4
by acetazolamide leads predictably to proximal RTA.
Important are other genetic diseases that cause a generalized
proximal tubular syndrome (Fanconi’s; e.g. cystinosis, fructose
intolerance, etc.) and drugs and toxins (e.g. ifosfamide [41],
lead, mercury and cadmium), but light chain disease occurs
among the elderly with proximal RTA. A number of
medications have been related to proximal RTA [42].
Characteristic of proximal RTA is the presence of bicarbona-
turia, with a fractional bicarbonate excretion of more than
15% when bicarbonate is given. Eventually, acid–base
balance and urine acidification is achieved as plasma
bicarbonate drops low enough for reabsorption to keep pace.
Treatment may be difficult because administered base is
often excreted before the desired normalization is achieved.
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Explaining acidosis in proximal RTA from the conventional
point of view is straightforward because the defining loss of
urinary bicarbonate will inevitably deplete the body and result
in hyperchloraemic acidosis. From the point of view of the
physicochemical approach, the reciprocal retention of Cl–
and resulting decline in SID will also explain the findings.
In the conventional notion of acid–base regulation, proximal
bicarbonate reabsorption is thought to be regulated by pH.
However, based on studies of bicarbonate transport in the
perfused rabbit proximal tubules, Boron and coworkers [43]
concluded that the observed regulation would require both a
CO2 sensor and a HCO3
– sensor. A pH sensor would not be
enough. Stoichiometrically, a HCO3
– sensor transmits the
same information as a hypothetical SID sensor, and the
results thus indicate that the proximal tubule senses the two
important independent variables in the Stewart model. These
quite new results could indicate that the physicochemical
approach is highly relevant to our understanding of the
mechanisms that underlie regulation of acid–base physiology.
Distal renal tubular acidosis (type 1)
dRTA is characterized by impaired ability to acidify the urine
in the distal tubules and it is often accompanied by hypo-
kalaemia, low urinary NH4
+ and hypocitraturia. In contrast to
proximal RTA, nephrocalcinosis and nephrolithiasis frequently
occur. Clinically, dRTA occurs as a primary (persistent or
transient) or secondary disorder. Secondary dRTA occurs in
a great number of circumstances related to autoimmune
diseases, drugs and toxins, and genetic or structural
disruptions of renal tubules. Treatment of dRTA is simple and
involves substituting about 1 mEq/kg of alkali per day.
The molecular details of some forms of primary dRTA are
being pursued in great detail. α-Intercalated cells secrete H+
by means of a vacuolar-type H-ATPase [44] (and possibly
also a H+/K+-type ATPase), and bicarbonate is exchanged for
Cl– by means of anion exchanger (AE1) at the basolateral
side. An autosomal dominant form of mutation in 17q21-22 of
SLC4A1 leads to dysfunction of AE1 possibly related to
mistargeting of the protein [45]. Also, AE1 mutations causing
autosomal recessive dRTA and haemolytic anaemia have
been described [46]. Otherwise, recessive forms of dRTA are
related to mutations in the proton pump in α-intercalated
cells. Some are accompanied by sensorineural deafness. The
gene involved (ATP6V1B1) is located on chromosome 2, and
encodes the B1-subunit of H+-ATPase expressed apically on
α-intercalated cells and also in the cochlea. dRTA with less
impaired hearing is related to mutation in ATP6V0A4 on
chromosome 7, which encodes a4, an accessory subunit of
H+-ATPase. As far as presently known, the H+ pumps are
electrogenic and, at least under some circumstances, they
also involve shunting of the potential by Cl–, although reverse
transport of K+ may also occur [44,47]. The Cl– shunt
pathway has not been elucidated yet nor aligned with any of
the many known Cl– channels [44]. Likewise, functional Cl–
channels (CIC5) are necessary to acidify transport vesicles in
Dent’s disease, pointing to the link between H+ and Cl–
transport [48].
Jentsch and coworkers [49] recently presented a detailed
examination of a mouse model that was knocked out for a
K+/Cl– cotransporter, KCC4, which is located in the baso-
lateral membrane in α-intercalated cells in the collecting duct.
These animals had metabolic acidosis with alkaline urine, but
electrolyte excretion in urine was unchanged compared with
controls. The investigators measured a high intracellular [Cl–]
and inferred a high intracellular pH also, driven by the basal
HCO3
–/Cl– exchanger AE1. Although intracellular pH was not
actually measured, and the defective cotransporter would be
expected also to result in increased intracellular [K+], the
results seem difficult to reconcile with a dominant effect of
intracellular SID to set intracellular pH and with the notion
that urine SID will have to change to explain acidosis in RTA.
Details are awaited for this model; the authors also failed to
document that conventional accounting for acid–base
balance would explain the findings (decreased NAE would
also change electrolyte excretion).
Recently, examination of the dRTA that is sometimes seen in
cyclosporine A treatment has led to deeper insights into the
tubular handling of protons and bicarbonate, but also – and
importantly – that of Cl–. In a study [50] of perfused rabbit
collecting ducts, cyclosporine A inhibited acidosis induced
downregulation of unidirectional HCO3
– secretory flux in β-
intercalated cells and prevented downregulation of the linked
Cl– resorption. Detailed examination of the apical and
basolateral exchanges indicates that, rather than responding
to, for example, intracellular pH, intracellular [Cl–] could be
the regulated entity [51]. If true, this interpretation is
compatible with a Stewart-based perspective.
A number of drugs and chemicals (e.g. amphotericin B [52],
foscarnet and methicillin) have been found occasionally to
cause dRTA [42], although details of the underlying
mechanisms are not available.
Type 3 renal tubular acidosis (carbonic anhydrase
dysfunction)
Type 3 RTA is caused by recessive mutation in the CA-2
gene on 8q22, which encodes carbonic anhydrase type 2
[53]. It is a mixed type RTA that exhibits both impaired
proximal HCO3
– reabsorption and impaired distal acidifi-
cation, and more disturbingly osteopetrosis, cerebral calcifi-
cation and mental retardation. The mechanisms that underlie
the clinical picture in type 3 RTA, apart from much slower
conversion of carbonic acid to and from bicarbonate,
apparently also involve direct interaction between CA and the
Na+/HCO3
– cotransporter kNBC1 [54] or Cl–/HCO3
–
exchanger SLC26A6 [55]. From the physicochemical inter-
pretation, acidosis is expected under these circumstances
because of impaired transport of SID components.
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Type 4 (hyperkalaemic) renal tubular acidosis
RTA type 4 or hyperkalaemic RTA is a heterogeneous group of
disorders that is characterized by low urine NH4
+, which is
probably caused by the hyperkalaemia or by aldosterone
deficiency or defective signalling. Causes include various types
of adrenal failure or pseudohypoaldosteronism (PHA)1 due to
defects in the mineralocorticoid receptor or the epithelial Na+
channel, all characterized by salt loss and hypotension. A
similar picture may be seen in obstructive uropathy or drug-
induced interstitial nephritis. Furthermore, a number of drugs
may impair signalling in the renin–aldosterone system and
cause hyperkalaemia and metabolic acidosis (e.g. potassium
sparing diuretics, trimethoprim, cyclo-oxygenase inhibitors,
angiotensin converting enzyme inhibitors).
Lately, much interest has been given to a group of rare
autosomal dominant diseases characterized by hyperkalaemia
and acidosis and age-related hypertension [56]. In spite of
hypervolaemia, aldosterone is not low and the disorders have
been collectively termed pseudohypoaldosteronism type 2
(PHA2) [57]. Two of the mutations have been mechanistically
characterized in some detail. Mutations in 17q21 in the
WNK4 gene may change the function of the protein, whereas
a mutation in the intron to the WNK1 gene at 12p increases
transcription of the protein. Briefly, WNK4 normally inhibits
the thiazide-sensitive cotransporter (TSC) in the distal
convolute tubule (DCT), and inhibits the renal outer medullar
K+ channel (ROMK) in the collecting duct (CD), but
enhances paracellular Cl– transport in both DCT and CD.
Mutations in the WNK4 gene that cause PHA2 are found to
release the normal inhibition of TSC, but at the same time
PHA2 enhances the inhibition of ROMK and enhances the
paracellular Cl– flux (but not Na+ flux) through claudins.
Hence, the hyperkalaemia is explained both by inhibition of
ROMK and by decreased delivery of Na+ to CD because of
enhanced absorption in the DCT, and the good effect of
thiazides on the hypertension is readily explained. The normal
explanation for metabolic acidosis is based on the decreased
delivery of Na+ to CD and thereby inhibition of generation of
lumen negative potential to enhance H+ secretion in
combination with the decreased delivery of NH4
+ secondary
to the hyperkalaemia [58].
The effect of the molecular abnormalities on Cl– transport is
barely considered in the explanation of the findings using the
conventional model of acid–base. From the physicochemical
approach it is evident that acidosis is well explained by the
dominant and primary enhancement of Cl– absorption in this
disorder. Even if only the TSC effect were invoked, an
isotonic expansion of body volume with Na+ and Cl– would
be expected to yield acidosis. In any case, SID in plasma will
decrease and pH will too. Very recently it was described that
WNK1 activates the epithelial Na+ channel [59], and this was
felt to explain the finding that not all patients with PHA2 are
equally sensitive to thiazides. This would be expected to
relieve the voltage imposed inhibition of H-ATPase in CD and
likewise lessen the degree of hyperkalaemia. Electrolyte and
NAE balance studies across different mutations may help to
clarify how acid–base balance is actually constructed in
these rare diseases.
Diagnosis and differential diagnosis
Traditionally, dRTA is recognized by the inability to decrease
urine pH below 5.5 in spite of metabolic acidosis. These
patients are also characterized by an inability to augment
NH4
+ excretion [60]. A high urine PCO2 after bicarbonate
loading has traditionally been the criterion for declaring distal
H+ secretion to be normal [61], and it was also recently found
to identify patients with confirmed dRTA due to a proton
pump problem [25].
Proximal RTA is characterized by high fractional excretion of
bicarbonate (>15%) during loading, and an ability to achieve
a urine pH below 5.5 during acidosis. Approaches are well
described by Soriano [31] and Smulders and coworkers [62].
When assessing urine to gauge whether the physicochemical
approach or the classical theory is best able to explain the
acidosis in RTA, it is possible that both will do so
successfully. From the physicochemical approach, the lack of
urine NH4
+ in distal RTA will force excretion of urine with a
relatively high SID and this will explain the acidosis. An old
study did in fact indicate that, in type 1 RTA, Na+ loss and to
a lesser degree Cl– handling was abnormal in spite of long-
term correction of acidosis [63].
The classical theory also explains the acidosis by a lack of
amplification of NH4
+ excretion. Likewise, for proximal RTA
bicarbonate loss and high SID excretion will be equivalent. It
was recently suggested that even though it may be difficult
mechanistically to separate the implications of the theories,
by using the physicochemical approach the focus is forced
toward movements of Na+ and Cl–, and this may lead to a
new understanding [2]. Indeed, analysis of WNK mutations
confirms this expectation.
Conclusion
From the clinical viewpoint, the advantage of employing the
physicochemical approach is that the renal contribution to
acid–base homeostasis, even in complicated settings, can be
ascertained in principle by simple chemical analysis of the
urine. It is possible to explain RTA in general as a
hyperchloraemic form of metabolic acidosis that can be
described as a low SID acidosis, which has focused attention
primarily on the net handling of SID constituents, namely Na+,
K+, and Cl–. This handling of SID constituents has not had a
central position in our understanding of the various disease
states, and in some cases only seems to be a consequence
of anions necessarily being filled in by Cl– as HCO3
– goes
down and reversely. However, in the future efforts will focus
on which transport mechanism is active (e.g. is Cl– moving
with H+ or K+ or against it to shunt the potential generated by
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the vacuolar H-ATPase [44]) and on which moiety is actually
regulated by the tubular processes. A number of studies have
recently focused on apical anion handling in the collecting
duct via a newly characterized transporter, namely pendrin
[64]. This exchanger seems well poised to react to Cl–
balance [65] and could therefore also be sensitive to the
independent variable in acid–base regulation (i.e. SID) [66].
One defining point in the physicochemical approach that has
an impact on the interpretation of acid–base phenomena is
the concept of [H+] as a dependent variable, which tends to
imply that clinical or physiological phenomena might more
fundamentally depend on the baseline independent variables
(e.g. SID, weak acids and PCO2). The necessity when
analyzing renal phenomena to differentiate metabolic and
respiratory acidosis may be an indicator that pH as such is
not actually the sensed quantity.
In fact, how derangements in acid–base balance are sensed
by the kidneys remains elusive, although there it is a general
belief that such detection happens there. Quite recently, a
protein, Pyk2, that was sensitive to pH and that regulated
isoform 3 of the Na+/H+ exchanger in the proximal tubules
was described [67]. Furthermore, in experiments identifying
this alleged pH sensor, SID was directly varied but PCO2 did
not change. Hence, it is not evident that pH was really
sensed, and in an accompanying editorial Gluck [68]
expressed reservations regarding this notion. As explained
above in relation to proximal RTA, recent studies conducted
by Boron and coworkers [43] indicate that that bicarbonate
and PCO2 are the regulated entities, rather than pH, which is
in accordance with the physicochemical approach to acid–
base physiology insofar as bicarbonate and SID are
equivalent.
Finally, if whole body acid–base balance is to be untangled,
then the intracellular domains, which are likely to vary, must
also be understood. In exercise physiology [69] advances
have been made using the Stewart approach in elucidating
plasma acid–base balance as it is perturbed by transfer of
putative independent influences, but modelling cells or whole
organs themselves from this point of view has not been done.
This will entail such difficulties as determining water structure
in cells and small confines [70] and modelling the pH effects
of the structural proteins and nucleic acids as they fold and
integrate. Modelling potassium balance in order to draw
inferences regarding intracellular SID will likewise be
necessary and interesting.
A recent study of patients in acute renal failure [71],
employing state of the art methods, found that almost 80% of
total body water appeared to be extracellular. This indicates
that a great deal of experimental work must be done before
analytical solutions [72] to the whole body multicompartment
system can be derived and applied in clinical practice. We
suggest that the physicochemical approach will prove useful
in formulating hypotheses for future work aimed at developing
a coherent, unpretentious and practical understanding of
mechanisms involved in renal acid–base regulation.
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